홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

5-((4-((2-Carboxyethyl)carbamoyl)phenyl)diazenyl)-2-hydroxybenzoic acid

HCID 54585
새 반응
인쇄
기본 정보개요이름 및 식별자물성화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
80573-04-2
표준 SMILES
O=C(O)CCNC(=O)c1ccc(N=Nc2ccc(O)c(C(=O)O)c2)cc1
InChIKey
IPOKCKJONYRRHP-UHFFFAOYSA-N
분자식
C17H15N3O6
평균 분자량
357.32 g/mol
단동위원소 질량
357.0960852

개요

Balsalazide is a monohydroxybenzoic acid consisting of 5-aminosalicylic acid (mesalazine) linked to 4-aminobenzoyl-beta-alanine via an azo bond. It has a role as a non-steroidal anti-inflammatory drug, an anti-ulcer drug, a prodrug and a gastrointestinal drug. It is a conjugate acid of a balsalazide(2-).

이름 및 식별자

우선 이름
5-((4-((2-Carboxyethyl)carbamoyl)phenyl)diazenyl)-2-hydroxybenzoic acid
IUPAC
5-[[4-(2-carboxyethylcarbamoyl)phenyl]diazenyl]-2-hydroxybenzoic acid
영어명
Balsalazide
분자식
C17H15N3O6
분자량
357.32

이름 및 동의어

5-((4-((2-carboxyethyl)carbamoyl)phenyl)diazenyl)-2-hydroxybenzoic acidDTXSID508610275-({4-[(2-Carboxyethyl)carbamoyl]phenyl}diazenyl)-2-hydroxybenzoic acidRefChem:1072307DTXCID10810339BALSALAZIDE80573-04-2BalsalazidoBalsalazidaBalsalazidumBalsalazidum [Latin]Balsalazida [Spanish]
이름 더 보기
CS-1360BalsalazineBalsalazide D4Balsalazide 98%BALSALAZIDE SODIUM
Balsalazido [Spanish](E)-5-((4-((2-Carboxyethyl)carbamoyl)phenyl)diazenyl)-2-hydroxybenzoic acidColazalGiazo(E)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acidColazideBalsalazide (INN)DTXSID7040653

데이터베이스 식별자

CAS
80573-04-2
PubChem CID
54585
DTXSID
DTXSID50861027
ChEMBL
CHEMBL1208641
ChEBI

물성

구조 계산 물성

XLogP
2.2
극성 표면적
149 Ų
수소 결합 공여자 수
4
수소 결합 수용자 수
8
회전 가능 결합 수
7
무거운 원자 수
26
형식 전하
0
복잡도
545

실험 및 물리화학적 성질

DrugsPharmaceuticals -> Listed in ZINC15
SolubilityFreely soluble as disodium salt

물리화학적 성질

녹는점
254 · 254-255C
끓는 점
729.6 · 729.6±60.0 °C(Predicted)
밀도
1.44 · 1.44±0.1 g/cm3(Predicted)
증기압
0 Pa · 0Pa at 20℃
저장 조건
-20 °C · -20°C Freezer
용해도
DMSO(약간 용해됨), 메탄올(약간 용해됨)
물리적 상태
고체
산도 계수 (pKa)
2.97 · 2.97±0.10(Predicted)
색상
노란색에서 베이지색
InChI
InChI=1S/C17H15N3O6/c21-14-6-5-12(9-13(14)17(25)26)20-19-11-3-1-10(2-4-11)16(24)18-8-7-15(22)23/h1-6,9,21H,7-8H2,(H,18,24)(H,22,23)(H,25,26)/b20-19+
InChIKey
IPOKCKJONYRRHP-FMQUCBEESA-N
SMILES
C(O)(=O)C1=CC(/N=N/C2=CC=C(C(NCCC(O)=O)=O)C=C2)=CC=C1O
LogP
1 at · 1 at 25℃ and pH7.5

화학 및 산업

약리 정보

Protein Binding≥99%
Pharmacodynamics · 1건

Balsalazide is a prodrug that has little or no pharmacologic activity until it is enzymatically cleaved in the colon to produce mesalamine (5-aminosalicylic acid), an anti inflammatory drug indicated for the treatment of mildly to moderately active ulcerative colitis. Balsalazide disodium is delivered intact to the colon where it is cleaved by bacterial azoreduction to release equimolar quantities of mesalamine, which is the therapeutically active portion of the molecule, and the intert 4-aminobenzoyl-(beta)-alanine. As a result, the spectrum of pharmacologic activity of balsalazide is similar to that of mesalamine.

Mechanism of Action · 1건

The mechanism of action of 5-aminosalicylic acid is unknown, but appears to exert its anti-inflammatory effects locally (in the GI tract) rather than systemically. Mucosal production of arachidonic acid metabolites, both through the cyclooxygenase pathways (catalyzes the formation of prostaglandin precursors from arachidonic acid), and through the lipoxygenase pathways (catalyzes the formation of leukotrienes and hydroxyeicosatetraenoic acids from arachidonic acid and its metabolites), is increased in patients with chronic inflammatory bowel disease. Therefore, it is possible that 5-aminosalicylic acid diminishes inflammation by blocking production of arachidonic acid metabolites in the colon through both the inhibition of cyclooxygenase and lipoxygenase.

Biological Half-LifeHalf-life could not be determined.
Metabolism/MetabolitesCleaved in the colon via bacterial azoreduction to 5–aminosalicylic acid (5–ASA) and 4–aminobenzoyl-beta-alanine, the inactive carrier moiety.
Absorption, Distribution and Excretion · 2건

Low and variable, intact balsalazide is poorly absorbed systemically.

The products of the azoreduction of this compound, 5-ASA and 4-aminobenzoyl-ß-alanine, and their N-acetylated metabolites have been identified in plasma, urine and feces. Following single-dose administration of 2.25 g COLAZAL (three 750 mg capsules) under fasting conditions in healthy subjects, mean urinary recovery of balsalazide, 5-ASA, and N-Ac-5-ASA was 0.20%, 0.22% and 10.2%, respectively.

관련 반응

5건
반응 기록 만들기
HRID 916723 반응식
HRID 916723생성물로
HRID 1750338 반응식
HRID 1750338반응물로
HRID 2202207 반응식
HRID 2202207반응물로
HRID 2205960 반응식
HRID 2205960반응물로
HRID 2272552 반응식
HRID 2272552반응물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성화학 및 산업관련 반응화합물 노트
CHEBI:267413
UNII
P80AL8J7ZP
EPA
5 · Benzoic acid, 5-[(1E)-2-[4-[[(2-carboxyethyl)amino]carbonyl]phenyl]diazenyl]-2-hydroxy- (80573-04-2)

화학적 성질

Yellow Solid

응용 분야 · 2건

개요Balsalazide is a prodrug form of 5-aminosalicylic acid (5-ASA; ). It is cleaved by bacterial azoreductases in the intestinal lumen to release 5-ASA. Balsalazide (600 mg/kg per day) decreases IL-2 levels and increases IL-6 levels in the serum and colonic mucosa membrane, as well as decreases micro- and macroscopic colonic damage, in a rat model of colitis induced by 2,4-dinitrochlorobenzene (DNCB). Formulations containing balsalazide have been used in the treatment of ulcerative colitis.

용도An analogue of Sulfasalazine, A prodrug of 5-Aminosalicylic Acid

상·하류 제품 정보

상류 원료

아질산 나트륨L-알라닌p-니트로벤조일클로라이드살리실산

추가 설명

정의ChEBI: A monohydroxybenzoic acid consisting of 5-aminosalicylic acid (mesalazine) linked to 4-aminobenzoyl-beta-alanine via an azo bond.